Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.

18:42 07/09/2023

Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.

Huaxi: Macro risk appetite rebounds, bulk metal related targets are expected to benefit.

After repeated fluctuations, A-shares are expected to rise again. What are the investment themes? The strategies of the top ten securities firms have arrived.

CITIC SEC: The market will focus on narrowing the circle and pay attention to four directions of AI hardware, resources, cyclical price increases, and dividends.

Huaxi: Macro risk appetite rebounds, bulk metal related targets are expected to benefit.

After repeated fluctuations, A-shares are expected to rise again. What are the investment themes? The strategies of the top ten securities firms have arrived.

CITIC SEC: The market will focus on narrowing the circle and pay attention to four directions of AI hardware, resources, cyclical price increases, and dividends.